Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AL139011.2		ENSG00000258465			1	160217464-160285130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0"									"HPA027218, HPA027381, HPA044837"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	8.6	4.0	3.7	3.0	10.2	2.0	4.4	15.4	11.4	4.8	4.7	8.6	2.5	3.5	6.3	4.2	5.3	6.4	4.6	16.7	3.8	3.9	6.2	10.8	4.1	3.2	3.6	5.9	7.6	4.0	6.7	4.1	5.0	9.1	5.5	3.5	6.1	5.5	3.0	14.6	4.0	4.2	7.8	4.1	3.7	4.3	4.8	4.1	2.5	7.9	3.8	3.4	5.8	4.7	5.8	8.9	6.7	6.5	8.0	5.0	8.0	0.1	2.1	0.3	0.5	6.7	1.9	0.6	0.9	5.9	3.3	0.8	0.0	0.8	0.2	6.6	1.0	5.2	0.8	1.1	0.2	0.0	6.0	0.0	0.3	0.7	0.2	3.4	0.0	0.3	3.2	0.2	3.0	3.4	3.5	0.5	0.8	1.0	4.7	0.5	0.3	1.1	0.0	0.3	0.6	0.6	0.5	0.0	0.3	0.3	0.8	0.6	0.8	0.2	1.4	0.0	1.0	2.8	5.6	0.0	0.8	0.8	0.0	0.2	0.8	3.4	0.5	0.4	0.3	0.3	6.4	6.3	6.2	3.6	6.5	5.0	5.8	4.4	4.7	8.9	3.9	2.5	3.2	6.7	8.0	6.3	2.5	4.9	8.0	3.7	10.2	15.4	11.4	3.8	3.9	3.6	5.9	9.1	4.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 338.2;Proximal tubular cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.5	6.0	17.8	20.1	12.5	20.3	3.8	9.3	16.1	6.1	9.5	2.4	10.5	8.1	7.4	11.1	5.5	8.0	6.6	9.4	10.2	12.2	0.7	19.3	5.4	9.6	15.6	4.2	4.0	16.0	7.3	4.8	8.1	15.1	18.0	12.9	20.1	16.0	29.0	12.1	12.0	6.2	1.1	22.4	18.2	10.2	4.7	14.4	29.8	26.6	0.8	6.7	14.0	132.5	11.1	0.5	17.0	10.9	16.3	10.3	4.9	13.5	5.5	8.1	6.1	9.5	9.8	9.6	13.1	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5	71.5	50.7	52.5	52.8	36.7	12.7	229.8	79.0	71.0	51.2	68.0	2.0	44.0	338.2	106.7	118.9	49.7	161.9	0.0	82.2	42.9	47.8	37.6	48.5	196.2	104.2	30.2	100.6	52.2	85.9	33.7	79.1	96.9	81.0	80.2	84.9	41.0	80.5	101.7	48.4	333.3	6.5	71.1	40.1	118.4	23.4	35.9	34.3	71.9	118.0	55.4
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No		63000	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	52.6	15.9	9.2	20.2	47.7	18.7	11.7	17.0	43.8	6.2	13.8	8.8	35.7	5.5	10.2	15.9	15.8	22.7	12.0	23.9	9.1	38.3	11.2	13.6	7.8	14.4	25.1	16.1	0.4	13.9	28.8	9.8	33.3	11.1	11.9	14.0	4.1	11.9	15.5	15.9	9.3	15.3	4.3	31.1	16.1	9.7	12.4	6.4	27.7	18.0	19.8	24.8	17.2	26.1	37.7	11.8	18.3	7.1	8.3	30.9	10.5	8.4	9.7	4.2	1.9	9.8	16.8	15.6	21.2	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0	50.6	96.5	40.4	57.0	30.2	23.6	16.5	147.7	46.8	59.1	82.0	78.5	22.0	16.6	184.7	1.5	65.9	155.6	0.0	145.2	76.8	60.2	242.6	172.3	147.5	88.2	39.7	44.6	30.1	58.9	2.0	76.2	101.1	102.9	178.5	77.9	88.0	174.5	89.2	79.2	41.6	54.4	84.1	70.6	1.1	3.1	22.2	17.4	135.7	66.0	41.6
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"		19	55158661-55166722	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	12	"fallopian tube: 29.7;testis: 60.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.2;Late spermatids: 540.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.3;HEL: 20.1;K-562: 15.7;U-937: 11.4"									HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No			Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.2	1.0	0.7	0.1	1.7	0.0	0.4	0.1	0.5	1.9	0.3	2.5	1.8	0.0	0.9	3.8	0.3	29.7	0.6	2.9	1.2	1.5	2.5	1.7	3.3	0.1	0.5	0.1	3.1	0.8	1.0	0.3	0.1	2.7	0.2	0.0	0.4	0.8	0.6	0.2	0.3	0.1	0.1	0.2	0.2	0.2	60.1	0.8	0.2	1.5	0.1	0.4	0.1	0.1	0.0	0.9	0.5	0.4	0.0	0.0	1.6	5.5	4.6	0.4	4.5	0.0	0.0	0.5	0.1	0.0	0.6	0.5	0.2	2.6	6.7	1.7	0.2	1.3	6.7	0.9	1.9	0.2	0.0	17.3	20.1	0.2	0.3	0.1	8.5	2.0	0.1	2.8	1.1	1.5	0.6	0.3	3.0	15.7	9.1	0.2	3.6	0.2	0.2	0.3	6.0	10.0	10.4	0.6	2.0	3.5	0.1	0.6	1.8	0.7	0.7	1.0	0.1	5.6	0.3	0.7	0.5	2.6	2.6	0.1	0.2	1.5	0.3	3.2	11.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.7	1.7	0.1	0.5	1.2	1.5	0.5	0.1	2.7	0.8	0.0	0.3	0.0	0.0	2.9	0.0	3.3	2.5	49.5	6.8	7.0	0.0	0.0	6.6	2.0	336.2	0.3	0.0	0.0	0.9	0.1	1.1	0.2	0.0	0.2	0.2	0.0	0.0	0.6	0.0	540.3	4.0	0.2	0.0	0.0	0.0	1.9	0.2	0.0	2.8	4.3	0.0	0.0	0.0	70.4	14.7	1.1	0.0	0.0	0.0	0.1
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 1.3;Cardiomyocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.7	0.0	0.0	5.1	0.2	0.0	0.0	0.0	3.6	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.1	2.2	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	5.5	2.4	0.0	7.3	0.6	0.1	0.0	0.1	0.0	17.2	0.2	0.0	0.1	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7	0.0	0.0	0.0	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.7	37.3	60.4	55.2	13.1	18.0	35.2	29.3	24.9	49.2	38.6	42.7	26.6	57.2	29.1	26.3	30.1	41.0	65.2	39.6	44.4	36.5	58.0	74.2	32.9	39.8	18.8	53.4	37.1	17.0	17.7	39.0	43.8	18.8	42.0	33.4	63.3	45.0	28.6	37.7	88.5	85.8	72.5	24.2	41.0	65.2	57.5	39.5	19.6	48.6	66.7	48.5	37.7	30.0	21.8	28.6	25.4	34.3	33.7	40.4	38.4	41.8	57.7	38.6	52.8	69.4	22.6	57.1	43.5	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0	92.3	128.4	63.8	84.3	76.5	92.4	59.0	50.9	96.4	131.9	40.1	80.5	65.6	23.2	66.6	12.8	60.9	40.0	46.7	69.0	90.4	57.8	80.9	92.6	46.1	63.0	89.0	109.3	33.7	53.5	14.4	70.8	66.0	37.1	46.9	68.0	70.5	72.3	56.1	58.7	38.2	92.6	32.3	67.0	108.6	117.8	67.2	59.3	68.2	82.6	87.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216511	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 114.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.9;NK-cells: 14.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	45.8	15.4	5.0	10.7	10.7	18.8	32.9	4.1	10.4	16.5	14.7	5.1	6.4	5.1	17.1	4.9	21.5	18.3	27.2	17.2	5.2	5.4	8.6	16.5	31.5	2.9	9.8	1.5	24.5	12.4	3.5	6.2	114.6	12.6	20.1	6.9	5.9	8.8	34.0	60.7	14.3	8.6	15.0	6.5	4.2	13.9	6.9	8.4	0.9	11.3	10.3	8.2	28.6	34.4	0.6	0.9	16.9	2.2	14.1	2.2	1.2	7.5	1.2	1.7	2.6	2.7	8.7	7.9	15.3	21.2	7.8	8.4	2.2	6.2	0.2	1.5	6.5	11.8	5.1	0.4	6.1	13.3	1.4	0.2	0.8	0.8	1.9	7.3	0.5	2.7	3.7	10.2	31.3	17.4	7.0	16.4	0.8	1.5	7.3	6.1	1.7	0.3	2.0	1.2	8.4	6.2	0.5	1.4	1.5	7.9	11.6	0.9	1.4	2.3	6.1	37.2	4.4	1.3	0.6	21.4	9.9	7.3	7.3	5.1	2.7	2.8	0.3	15.0	0.6	6.2	16.9	0.3	0.2	2.2	0.5	2.1	0.6	1.2	1.5	0.9	0.4	1.6	1.2	5.9	14.1	2.2	0.1	0.5	1.2	5.0	10.7	4.1	10.4	5.2	5.4	9.8	1.5	12.6	8.4	50.6	43.7	7.5	289.5	111.8	2.2	13.7	33.1	29.4	33.0	10.4	0.0	30.6	6.6	37.6	0.4	35.0	98.6	0.0	21.5	52.9	80.2	257.7	21.9	5.0	23.2	0.0	100.5	14.7	7.8	0.0	9.2	26.4	55.6	17.2	43.3	16.8	51.3	62.0	3.5	2.4	2.0	19.4	116.4	0.9	1.0	90.2	400.7	27.7	35.7	321.4
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469688-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	20.1	17.6	17.2	19.3	23.6	35.7	26.9	28.9	25.8	17.8	17.8	21.2	18.7	15.0	29.1	22.3	17.4	21.7	12.1	14.8	17.6	15.7	20.6	21.0	15.5	20.4	23.5	17.4	27.2	16.6	20.9	20.7	19.7	19.1	19.7	19.4	17.4	24.0	19.9	32.8	22.7	17.9	21.0	21.6	19.7	17.5	19.0	25.2	19.6	23.7	17.2	22.8	17.3	19.7	42.0	26.7	18.9	23.4	35.2	44.6	28.2	11.0	21.9	16.8	15.7	16.3	11.8	22.2	14.6	15.3	31.3	25.4	21.6	20.2	27.4	10.8	13.3	22.2	19.2	33.2	18.1	36.9	18.2	17.5	24.5	13.3	66.7	22.2	32.4	17.5	14.7	23.1	24.6	29.4	12.4	15.8	21.2	27.1	19.6	15.2	26.2	24.1	24.5	21.2	25.4	29.5	19.7	20.1	14.0	20.0	21.0	17.2	19.4	17.3	20.8	23.9	17.8	12.9	20.8	11.9	14.8	17.6	13.9	21.2	24.5	42.5	39.8	6.4	16.6	15.8	17.5	21.5	18.9	31.6	23.4	33.5	42.0	34.3	32.1	25.3	36.6	44.6	35.1	6.6	35.2	22.4	26.7	37.4	28.2	17.2	23.6	28.9	25.8	17.6	15.7	23.5	17.4	19.1	25.2	32.8	26.9	41.2	49.3	62.7	21.0	17.7	17.8	28.1	29.6	26.2	15.7	50.7	28.2	31.1	4.1	34.3	17.4	23.3	31.3	36.0	37.0	25.4	43.9	18.1	26.5	23.8	23.6	16.0	16.4	4.5	32.5	29.5	30.4	36.1	18.8	20.7	28.1	19.9	26.5	27.0	24.7	19.4	38.7	57.2	69.0	59.1	47.8	41.5	22.0	44.2
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.1	20.7	1.5	0.0	13.6	15.2	1.8	15.9	19.1	13.8	15.9	1.5	13.6	9.0	7.3	23.3	16.1	9.6	0.1	12.5	17.1	5.0	7.1	2.3	28.0	4.5	12.8	9.3	7.2	11.0	16.2	22.6	22.1	17.2	5.1	4.1	3.3	34.3	12.1	3.6	5.4	6.6	4.1	1.7	4.4	1.9	14.4	19.1	4.0	0.7	2.7	2.1	27.8	4.0	6.6	1.8	1.8	13.4	12.2	33.4	6.6	15.9	12.0	6.9	6.3	14.1	17.5	9.6	11.6	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2	62.5	66.3	52.2	35.5	52.2	11.3	38.3	43.3	45.5	46.6	24.4	15.7	34.4	14.9	27.4	129.9	67.3	15.8	0.0	28.6	30.5	63.9	36.5	86.6	160.0	47.2	35.0	27.0	55.3	56.4	113.7	58.4	78.4	50.6	53.3	2.3	41.2	29.3	21.0	67.1	50.1	55.0	148.8	81.5	18.0	35.6	49.2	30.6	85.5	12.0	12.3
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Rod photoreceptor cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	18.5	22.6	24.2	28.9	24.9	9.7	32.4	49.7	27.3	20.1	14.9	21.1	19.2	14.9	26.0	33.5	15.2	17.2	21.2	26.2	19.8	20.2	22.9	20.2	20.0	25.6	18.5	22.8	38.9	18.1	20.4	21.8	26.3	18.0	19.9	13.6	57.8	20.5	16.9	25.7	42.1	15.7	17.3	19.6	22.1	13.7	17.0	18.2	31.2	19.5	10.5	18.5	17.7	18.1	9.5	7.5	8.3	6.6	14.1	18.1	7.9	10.9	4.0	15.9	12.4	15.4	19.1	15.2	6.8	7.5	9.9	6.1	9.4	17.6	16.4	12.1	8.1	7.8	13.6	8.7	11.0	13.4	3.5	11.9	7.9	17.9	15.7	13.0	8.2	12.1	27.0	15.3	5.2	9.0	17.7	14.3	16.7	14.5	14.8	8.0	7.1	18.8	27.1	11.7	15.2	16.9	15.7	6.3	19.5	15.0	12.7	25.3	29.9	13.0	15.0	17.5	26.0	16.0	16.5	10.4	14.9	5.3	9.5	5.4	18.0	14.6	15.8	9.8	8.7	8.6	7.6	6.6	7.6	8.4	4.5	10.0	8.9	12.5	9.5	7.5	9.5	17.7	12.7	8.3	14.1	4.1	4.7	18.1	7.9	24.2	24.9	49.7	27.3	19.8	20.2	18.5	22.8	18.0	18.2	20.8	21.1	17.1	14.0	18.1	110.9	54.5	20.4	30.8	22.7	27.9	88.4	26.4	19.9	6.5	7.3	34.6	6.7	46.7	7.9	6.2	23.4	15.8	12.7	26.8	12.1	35.0	21.9	52.8	33.3	8.2	39.7	12.8	45.5	5.4	18.1	55.9	9.2	16.7	29.0	18.4	170.0	25.8	19.8	42.9	28.3	18.6	18.3	17.5	14.0	7.8
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.7;HMC-1: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		7100000	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.9	5.6	2.8	2.0	1.7	4.3	1.5	0.0	0.3	1.8	0.0	13.7	7.7	10.6	2.5	0.0	1.2	37.7	1.9	0.0	2.3	2.2	41.9	1.9	13.2	1.9	6.3	1.8	4.0	0.0	9.0	0.0	8.8	1.3	0.3	0.0	0.9	0.0	0.0	0.0	2.9	1.8	4.2	13.8	0.1	0.8	0.9	3.9	0.1	11.4	12.4	4.4	2.9	0.2	3.2	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2	11.9	15.2	6.9	15.7	12.2	0.6	2.8	2.5	2.7	13.6	0.0	0.0	21.1	3.3	8.8	1.9	2.2	0.4	0.0	3.3	2.5	3.8	21.9	41.7	16.3	12.6	0.0	1.2	10.4	40.3	5.0	2.6	35.6	6.8	6.4	2.6	9.5	20.5	0.0	2.1	2.9	0.2	6.5	6.2	0.5	1.1	8.9	7.3	12.5	2.2	17.0
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.5	12.5	2.1	9.4	7.2	2.8	5.2	2.9	2.7	3.3	3.6	1.5	11.7	5.2	3.1	3.4	6.7	10.1	2.7	3.6	1.8	2.8	3.3	4.4	9.2	1.8	2.7	0.5	11.9	5.9	2.1	6.2	1.1	2.3	5.1	6.1	1.2	1.8	2.7	2.5	4.7	2.4	0.7	3.1	4.2	5.1	1.5	2.3	2.5	11.6	1.1	2.8	8.6	5.2	3.7	2.3	11.6	3.3	6.7	2.2	1.7	5.3	2.5	4.0	2.4	1.8	5.7	7.8	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2	0.0	4.8	5.4	1.5	0.7	3.7	1.2	2.5	0.0	1.2	10.4	7.9	7.3	10.0	2.4	2.4	2.2	2.5	0.0	6.2	2.0	1.3	1.8	4.7	2.4	5.9	1.6	8.6	2.5	3.7	3.6	1.4	2.7	0.0	8.2	2.7	6.8	2.6	3.1	1.1	5.7	8.9	0.0	0.7	27.9	0.7	0.3	14.5	3.8	3.0	1.1
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 208.6;Proximal tubular cells: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.2	3.0	1.4	22.3	10.1	9.6	5.0	13.5	1.5	3.3	1.6	1.3	0.0	0.7	3.1	4.1	2.4	0.8	2.5	1.3	0.0	2.6	1.1	5.1	4.2	14.3	0.0	0.0	12.3	18.3	1.4	2.7	6.0	2.7	0.0	1.8	0.0	6.2	4.4	0.0	0.1	0.5	28.0	3.9	0.0	5.3	0.1	7.4	2.0	2.2	0.0	0.7	9.1	12.7	2.0	1.5	0.7	5.2	3.0	1.7	0.3	3.2	0.0	0.0	0.0	4.3	2.3	6.7	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2	3.0	16.2	2.2	20.4	47.7	2.8	3.6	22.9	5.3	3.4	5.2	3.9	117.9	48.0	19.1	0.1	5.8	208.6	0.0	22.5	35.4	27.9	13.5	9.3	67.1	54.3	3.2	46.8	24.5	86.5	1.1	14.4	9.9	33.7	1.0	51.3	11.4	17.1	87.7	13.4	122.4	5.9	12.9	8.3	0.9	3.9	66.5	96.2	4.3	33.0	12.8
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	4.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	0.0	3.6	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.9	0.5	7.5	7.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.4	0.0	1.6	0.1	0.0	0.0	7.7	9.5	0.0	0.2	0.4	0.0	1.8	0.2	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5	6.0	64.7	0.8	1.1	1.0	0.0	1.2	5.1	2.7	12.5	3.5	0.0	0.1	0.0	4.8	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.0	3.5	0.9	16.3	0.0	0.0	2.5	106.5	0.0	0.6	52.5	1.7	0.0	0.1	0.0	3.1	0.0	0.4	1.0	0.3	12.9	0.4	0.2	0.4	1.0	0.1	0.7	0.0	1.4
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	11.7	19.5	16.1	12.1	23.9	8.1	23.6	15.0	23.9	16.8	21.2	38.9	16.3	18.1	16.2	18.3	19.8	23.0	25.1	10.8	18.8	15.2	14.2	47.6	11.7	12.2	26.1	27.3	20.6	26.7	18.3	14.3	11.1	27.6	24.3	24.3	14.7	25.0	19.4	11.9	32.5	16.5	14.3	23.6	13.5	33.0	16.4	23.1	17.3	12.5	11.4	12.1	14.4	17.5	6.1	7.3	13.3	10.0	11.7	7.5	4.5	9.2	6.8	18.1	19.8	18.7	22.8	6.8	10.4	12.7	6.2	6.3	4.1	8.8	10.5	13.3	11.6	11.0	7.7	10.4	9.0	12.0	10.1	6.4	8.5	8.3	10.6	10.6	16.1	10.2	15.3	14.4	8.4	28.3	17.0	13.7	12.5	19.5	9.2	12.3	12.3	15.3	9.6	7.3	17.4	8.6	9.1	9.2	9.4	10.5	14.6	21.1	25.2	16.2	21.3	18.3	10.8	10.8	10.8	20.6	13.7	13.4	15.9	10.5	10.7	18.5	10.9	9.3	11.6	17.9	13.3	4.7	5.0	6.8	4.0	6.7	5.1	5.4	6.7	7.3	6.1	7.5	5.3	5.3	11.7	10.0	5.2	4.3	4.5	16.1	23.9	15.0	23.9	18.8	15.2	26.1	27.3	27.6	23.1	23.8	39.4	30.6	38.6	13.4	91.6	37.3	142.7	161.9	56.9	43.6	141.4	32.1	13.3	46.0	35.7	43.9	59.0	0.0	38.3	12.7	32.9	84.1	33.6	124.6	17.1	84.2	212.3	35.6	28.8	14.6	47.5	27.1	38.8	27.9	82.8	74.9	41.8	84.2	50.2	23.0	68.3	19.4	22.2	28.9	14.6	18.7	55.2	18.7	98.9	47.9
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.9	13.5	1.5	3.4	7.2	2.7	2.7	4.1	4.4	2.6	2.6	8.3	7.2	1.2	2.2	4.0	7.0	1.8	6.8	3.5	13.4	3.9	2.5	1.6	2.7	6.6	10.6	3.0	3.4	2.5	5.3	3.1	3.9	9.3	9.9	13.1	4.5	1.7	9.1	2.3	10.4	3.0	5.4	7.1	7.7	3.2	3.0	6.5	5.1	9.9	4.1	4.9	2.0	6.1	6.8	8.4	2.5	5.1	4.9	4.6	5.6	4.2	9.6	9.1	2.1	1.2	5.3	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5	3.0	5.3	4.7	3.6	2.1	11.6	3.6	5.1	5.3	4.5	3.5	3.9	1.8	1.7	3.3	0.6	4.7	1.5	0.0	4.4	2.1	3.4	5.6	3.5	1.6	1.4	1.6	9.2	3.7	3.7	0.2	6.9	2.2	0.0	1.8	3.9	4.2	2.9	4.5	2.5	1.1	6.7	0.0	2.1	7.2	10.0	0.5	1.1	7.5	2.6	3.4